Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1628-1633
Published online before print July 1, 2004, doi: 10.1161/01.ATV.0000137188.76195.fb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
24/9/1628    most recent
01.ATV.0000137188.76195.fbv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamilton, K. L.
Right arrow Articles by Knowlton, A.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamilton, K. L.
Right arrow Articles by Knowlton, A.A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1628.)
© 2004 American Heart Association, Inc.


Vascular Biology

Estrogen, Heat Shock Proteins, and NF{kappa}B in Human Vascular Endothelium

Karyn L. Hamilton; F.N. Mbai; S. Gupta; A.A. Knowlton

From the University of California (F.N.M., S.G., A.A.K.), Davis, Calif; Sacramento VA Medical Center (A.A.K.), Sacramento, Calif; and Baylor College of Medicine (K.L.H.), Houston, Tex.

Correspondence to Dr A.A. Knowlton, Cardiovascular Division, TB 172, University of California, Davis, One Shields Avenue, Davis, CA 95616. E-mail aaknowlton{at}ucdavis.edu

Background— We hypothesized that estrogen would increase HSP72 in human coronary artery endothelial cells (HCAEC), and that these would be more sensitive to estrogen than our previous observations in myocytes.

Methods and Results— HCAEC were treated with 17ß-estradiol or tamoxifen, ranging from physiological to pharmacological(1 nM to 10 µmol/L) for either 24 hours (early) or 7 days (chronic). HSP expression was assessed by Western blots. Both early and chronic 17ß-estradiol and tamoxifen increased HSP72. Electromobility shift assays (EMSA) showed activation of HSF-1 with early, but not chronic, 17ß-estradiol. 17ß-Estradiol activated NF{kappa}B within 10 minutes, and the ER-{alpha} selective inhibitor, ICI 182 780, abolished this effect. Transcription factor decoys containing the heat shock element blocked HSP72 induction. Estrogen pretreatment decreased lactate dehydrogenase release with hypoxia. This protective effect persisted despite blockade of HSF-1 by decoys. However, an NF-{kappa}B decoy prevented the increase in HSP72 and abolished the estrogen-associated protection during hypoxia.

Conclusions— 17ß-Estradiol upregulates HSP72 early and chronically via different mechanisms in HCAEC, and provides cytoprotection during hypoxia, independent of HSP72 induction. NF-{kappa}B mediates the early increase in HSP72, suggesting that estrogen activates NF-{kappa}B via a nongenomic, receptor-dependent mechanism, and this leads to activation of HSF-1. Activation of NF-{kappa}B was critical for estrogen-associated protection. Further studies are needed to elucidate the involved signaling pathways.

We hypothesized that estrogen would increase HSP72 in human coronary artery endothelial cells (HCAEC). Both early and chronic treatment increased HSP72. EMSA showed activation of HSF-1 with early, but not chronic, 17ß-estradiol. Transcription factor decoys blocked estrogen-related HSP72 induction. Estrogen decreased LDH release with hypoxia. An NF-{kappa}B decoy blocked the HSP72 increase and estrogen-associated protection.


Key Words: estrogen • endothelium • signal transduction • hypoxia • HSP72




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
C. L. Stebbins, J. P. Stice, C. M. Hart, F. N. Mbai, and A. A. Knowlton
Effects of Dietary Decosahexaenoic Acid (DHA) on eNOS in Human Coronary Artery Endothelial Cells
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2008; 13(4): 261 - 268.
[Abstract] [PDF]


Home page
Physiol. GenomicsHome page
K. L. Hamilton, L. Lin, Y. Wang, and A. A. Knowlton
Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression
Physiol Genomics, January 17, 2008; 32(2): 254 - 263.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Nickerson, S. L. Kennedy, J. D. Johnson, and M. Fleshner
Sexual dimorphism of the intracellular heat shock protein 72 response
J Appl Physiol, August 1, 2006; 101(2): 566 - 575.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A.A. Knowlton
NF{kappa}B, heat shock proteins, HSF-1, and inflammation
Cardiovasc Res, January 1, 2006; 69(1): 7 - 8.
[Full Text] [PDF]